Nothing Special   »   [go: up one dir, main page]

GR3035155T3 - Broadly reactive opsonic antibodies that react with common staphylococcal antigens. - Google Patents

Broadly reactive opsonic antibodies that react with common staphylococcal antigens.

Info

Publication number
GR3035155T3
GR3035155T3 GR20000402843T GR20000402843T GR3035155T3 GR 3035155 T3 GR3035155 T3 GR 3035155T3 GR 20000402843 T GR20000402843 T GR 20000402843T GR 20000402843 T GR20000402843 T GR 20000402843T GR 3035155 T3 GR3035155 T3 GR 3035155T3
Authority
GR
Greece
Prior art keywords
react
broadly reactive
opsonic antibodies
staphylococcal antigens
reactive opsonic
Prior art date
Application number
GR20000402843T
Other languages
English (en)
Inventor
Gerald W Fischer
Original Assignee
Us Gov Sec Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26709752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3035155(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Us Gov Sec Army filed Critical Us Gov Sec Army
Publication of GR3035155T3 publication Critical patent/GR3035155T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/085Staphylococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56938Staphylococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR20000402843T 1992-03-19 2000-12-27 Broadly reactive opsonic antibodies that react with common staphylococcal antigens. GR3035155T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85402792A 1992-03-19 1992-03-19
US3347693A 1993-03-18 1993-03-18
PCT/US1993/002275 WO1993019373A1 (en) 1992-03-19 1993-03-18 Broadly reactive opsonic antibodies that react with common staphylococcal antigens

Publications (1)

Publication Number Publication Date
GR3035155T3 true GR3035155T3 (en) 2001-04-30

Family

ID=26709752

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402843T GR3035155T3 (en) 1992-03-19 2000-12-27 Broadly reactive opsonic antibodies that react with common staphylococcal antigens.

Country Status (12)

Country Link
EP (3) EP1033135A1 (el)
JP (3) JP4124816B2 (el)
AT (1) ATE197506T1 (el)
AU (1) AU3805893A (el)
CA (1) CA2132421C (el)
DE (1) DE69329642T3 (el)
DK (1) DK0635132T4 (el)
ES (1) ES2155450T5 (el)
GR (1) GR3035155T3 (el)
IL (1) IL105119A (el)
PT (1) PT635132E (el)
WO (1) WO1993019373A1 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US6632432B1 (en) 1990-10-22 2003-10-14 Henry M. Jackson Foundation For The Advancement Of Military Medicine Directed human immune globulin for the prevention and treatment of staphylococcal infections
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
DK0783520T3 (da) * 1994-09-21 2002-03-25 Jackson H M Found Military Med Bredt reaktive opsoniske antistoffer, som er reaktive mod fælles stafylokok-antigener
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
AU2006203322B2 (en) * 1997-06-16 2010-04-29 Altor Bioscience Corporation Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
EP1173485A1 (en) * 1999-05-03 2002-01-23 Medarex, Inc. Human antibodies to staphylococcus aureus
US7723087B2 (en) 2002-11-12 2010-05-25 The Brigham And Women's Hospital, Inc. Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof
JP5814494B2 (ja) 2002-11-12 2015-11-17 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. Staphylococcus感染に対する多糖類ワクチン
EP2455400B1 (en) 2004-04-21 2019-03-20 The Brigham and Women's Hospital, Inc. Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
EP2213298A3 (en) 2004-10-21 2011-07-20 Wyeth LLC Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens
DE602006021324D1 (de) * 2005-08-23 2011-05-26 Iq Corp Verfahren zur herstellung stabiler b-lymphozyten
PL1821053T3 (pl) 2006-01-31 2016-04-29 Electrolux Home Products Corp Nv Urządzenie do szybkiego schładzania napojów i sposób jego kontrolowania
EP2315747B1 (en) 2008-07-21 2017-12-06 The Brigham and Women's Hospital, Inc. Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
SA110310528B1 (ar) 2009-06-22 2014-07-02 Wyeth Llc التركيبات المولدة للمناعة لأنتيجينات ستافيلوكوكس أوريس

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
WO1988004669A1 (en) * 1986-12-15 1988-06-30 Mitsui Toatsu Chemicals, Inc. Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
CA2117480A1 (en) * 1992-02-25 1993-09-02 Gerald W. Fischer Directed human immune globulin for the prevention and treatment of staphylococcal infections

Also Published As

Publication number Publication date
CA2132421C (en) 2010-11-23
JP4353974B2 (ja) 2009-10-28
IL105119A0 (en) 1993-08-18
EP0635132A1 (en) 1995-01-25
DE69329642T2 (de) 2001-03-15
ES2155450T3 (es) 2001-05-16
JP4124816B2 (ja) 2008-07-23
JP2007119468A (ja) 2007-05-17
JPH07507387A (ja) 1995-08-10
CA2132421A1 (en) 1993-09-20
ATE197506T1 (de) 2000-11-11
JP4171596B2 (ja) 2008-10-22
EP1033135A1 (en) 2000-09-06
EP0635132B1 (en) 2000-11-08
DE69329642T3 (de) 2009-05-20
DE69329642D1 (de) 2000-12-14
EP1027896A1 (en) 2000-08-16
IL105119A (en) 1999-06-20
DK0635132T4 (da) 2008-08-25
WO1993019373A1 (en) 1993-09-30
AU3805893A (en) 1993-10-21
PT635132E (pt) 2001-03-30
EP0635132B2 (en) 2008-05-14
DK0635132T3 (da) 2001-02-26
JP2002255998A (ja) 2002-09-11
ES2155450T5 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
GR3035155T3 (en) Broadly reactive opsonic antibodies that react with common staphylococcal antigens.
WO1998057994A3 (en) Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
JP4656728B2 (ja) ブドウ球菌抗原及びワクチン
EP0077734A3 (en) Production of monoclonal antibodies against bacterial adhesins
CA2132953A1 (en) Monospecific polyclonal antibodies to shiga-like toxins
ATE425251T1 (de) Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen
EP0866133A3 (en) A group b streptococcus vaccine
FR2746398B1 (fr) Anticorps specifique de staphylococcus aureaus, et utilisations
CA2145397A1 (en) Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
EP0350690A3 (de) Neutralisation der in vitro- und in vivo-toxischen Eigenschaften von TNF-alfa durch monoklonale Antikörper und die davon abgeleiteten Fragmente
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
GB1505513A (en) Dental caries inhibiting product
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
NZ331557A (en) Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
AU3637195A (en) Broadly reactive opsonic antibodies reactive with common staphylococcal antigens
Valentin-Weigand et al. Role of α2-macroglobulin in phagocytosis of group A and C streptococci
AU3018289A (en) Anaplasma marginale antigen, antigen compositions, vaccine and process for the production of said antigen, antigen compositions, and vaccine
GB8704648D0 (en) Antibodies
CA2091967A1 (en) Monoclonal anti-ganglioside antibody, its preparation and use as a tumor therapeutic agent
EP0450573A3 (en) Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
PT998493E (pt) Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos
DE68924963D1 (de) Zusammensetzungen und Methoden zur Behandlung und Vorbeugung von Gram-Negativen-Infektionen.
Iastrebova et al. Comparative immunochemical characteristics of extracellular polysaccharide-containing preparations and teichoic acids of Staphylococcus aureus
RU95104325A (ru) Коньюгаты антител с улучшенными свойствами